2019
DOI: 10.1089/jmf.2018.4323
|View full text |Cite
|
Sign up to set email alerts
|

Cottonseed Oil Protects Against Intestinal Inflammation in Dextran Sodium Sulfate-Induced Inflammatory Bowel Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
45
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(45 citation statements)
references
References 27 publications
0
45
0
Order By: Relevance
“…It represents a series of chronic relapsingremitting gastrointestinal tract disorders characterized by a persistent intestinal inflammation with clinical symptoms of abdominal pain, blood in stool, weight loss, diarrhea, fatigue, or maldigestion (Hanauer and Hommes, 1996;Yu and Rodriguez, 2017). The precise pathogenesis of IBD is not exactly known, however, some researchers agree that IBD is associated with environmental factors, intestinal microbiota disorder, abnormal autoimmune responses, and genetic susceptibility (Danese and Fiocchi, 2006;Italia and Claudio, 2015;Park et al, 2019). To date, the treatment options of IBD are mainly concentrated on conventional therapies, including non-specific immunosuppressive therapies, antibiotics and anti-inflammatory agents, which have low efficacy and may even cause many side effects (Baumgart and Sandborn, 2007;Yamamoto-Furusho, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…It represents a series of chronic relapsingremitting gastrointestinal tract disorders characterized by a persistent intestinal inflammation with clinical symptoms of abdominal pain, blood in stool, weight loss, diarrhea, fatigue, or maldigestion (Hanauer and Hommes, 1996;Yu and Rodriguez, 2017). The precise pathogenesis of IBD is not exactly known, however, some researchers agree that IBD is associated with environmental factors, intestinal microbiota disorder, abnormal autoimmune responses, and genetic susceptibility (Danese and Fiocchi, 2006;Italia and Claudio, 2015;Park et al, 2019). To date, the treatment options of IBD are mainly concentrated on conventional therapies, including non-specific immunosuppressive therapies, antibiotics and anti-inflammatory agents, which have low efficacy and may even cause many side effects (Baumgart and Sandborn, 2007;Yamamoto-Furusho, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…TNF‐ α is an important cytokine during the onset of inflammatory responses, as it promotes T cell differentiation and proliferation, the destruction of the intestinal barrier, and the rapid development and progression of intestinal inflammation 41 . IL‐1 β is also an essential cytokine in the early stages of inflammation, provoking continuous inflammatory responses in colon tissues 42 . After SePSP treatment, therefore, the substantial reduction in the mRNA levels of the proinflammatory cytokines, TNF‐ α and IL‐1 β , in the colon tissues of mice with DSS‐induced UC indicated that SePSP has potential immunomodulatory efficacy in the treatment of colitis.…”
Section: Discussionmentioning
confidence: 99%
“…A prospective study including 412 patients with quiescent UC treated with an aminosalicylate, reported that dietary intake of myristic acid, a SFA commonly found in palm oil, coconut oil and dairy fats was associated with increased risk of a flare (OR 3.01; 95% CI: 1.17-7.74) [30]. Coconut oil could not demonstrate a beneficial effect in DSS-induced colitis in mice [144].…”
Section: Coconut Oilmentioning
confidence: 99%